Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119415 · ClinicalTrials.gov registry record · NA
Enlisting Peer Cooperation and Prosociality in the Service of Substance Use Prevention in Middle School
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,064
- Enrollment target
NCT03119415: Completed NA study, sponsored by Oregon Research Institute.
NCT03119415 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 2,064 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03119415, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,064 participants
- Enrollment target
Study Summary
Students' cooperative and prosocial behavior is vital to their social and academic success and to the quality of a school's social environment. This project will evaluate an instructional technique that could benefit students and schools by encouraging higher levels of prosocial behavior among students and promoting social integration and inclusion, particularly for marginalized students. The instructional technique is called "cooperative learning" which involves students working in groups toward shared academic goals. Previous research indicates that cooperative learning promotes social acceptance and increases academic engagement and achievement. However, it has not been evaluated as a technique to reduce student behavioral problems and promote greater school safety. There is strong reason to believe that it will have these benefits, since cooperative learning brings together students from diverse social groups and provides them the opportunity to work together toward shared goals in a positive setting.
Primary Outcome
Tobacco, alcohol, and marijuana; actual use, intentions to use, willingness to use
Interventions
- BEHAVIORAL Cooperative Learning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,064 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03119415 record still lists
NCT03119415 is an interventional study that assigns participants to a tested intervention. Its 2,064 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 1 intervention - of which Cooperative Learning is the first listed.
NCT03119415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03119415 about?
NCT03119415 is a clinical study titled "Enlisting Peer Cooperation and Prosociality in the Service of Substance Use Prevention in Middle School". Students' cooperative and prosocial behavior is vital to their social and academic success and to the quality of a school's social environment. This project will evaluate an instructional technique that could benefit students and schools by encouraging higher levels of prosocial behavior among stude...
What is the current status of trial NCT03119415?
This trial is currently completed. It is a NA study. The enrollment target is 2,064 participants. The study started on 2016-07-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03119415?
The interventions under investigation include: Cooperative Learning (BEHAVIORAL).
Who is sponsoring clinical trial NCT03119415?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03119415's enrollment target sits among peer trials
2,064 50th of 2000 higher than 1,951 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI